Correlation Between Laboratorios Farmaceuticos and ENCE Energa

Can any of the company-specific risk be diversified away by investing in both Laboratorios Farmaceuticos and ENCE Energa at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Laboratorios Farmaceuticos and ENCE Energa into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Laboratorios Farmaceuticos ROVI and ENCE Energa y, you can compare the effects of market volatilities on Laboratorios Farmaceuticos and ENCE Energa and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Laboratorios Farmaceuticos with a short position of ENCE Energa. Check out your portfolio center. Please also check ongoing floating volatility patterns of Laboratorios Farmaceuticos and ENCE Energa.

Diversification Opportunities for Laboratorios Farmaceuticos and ENCE Energa

0.32

Correlation Coefficient

Laboratorios Farmaceuticos  ENCE Energa

Weak diversification

The 3 months correlation between Laboratorios and ENCE is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Laboratorios Farmaceuticos ROV and ENCE Energa y in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ENCE Energa y and Laboratorios Farmaceuticos is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Laboratorios Farmaceuticos ROVI are associated (or correlated) with ENCE Energa. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ENCE Energa y has no effect on the direction of Laboratorios Farmaceuticos i.e., Laboratorios Farmaceuticos and ENCE Energa go up and down completely randomly.

Pair Corralation between Laboratorios Farmaceuticos and ENCE Energa

Assuming the 90 days trading horizon Laboratorios Farmaceuticos ROVI is expected to under-perform the ENCE Energa. In addition to that, Laboratorios Farmaceuticos is 1.51 times more volatile than ENCE Energa y. It trades about -0.12 of its total potential returns per unit of risk. ENCE Energa y is currently generating about 0.05 per unit of volatility. If you would invest  290.00  in ENCE Energa y on September 16, 2024 and sell it today you would earn a total of  11.00  from holding ENCE Energa y or generate 3.79% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Laboratorios Farmaceuticos ROV  vs.  ENCE Energa y

Laboratorios Farmaceuticos

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Laboratorios Farmaceuticos ROVI has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unsteady performance in the last few months, the Stock's fundamental indicators remain rather sound which may send shares a bit higher in January 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.

ENCE Energa y

Risk-Adjusted Performance

3 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in ENCE Energa y are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather sound fundamental indicators, ENCE Energa is not utilizing all of its potentials. The latest stock price tumult, may contribute to shorter-term losses for the shareholders.

Pair Trading with Laboratorios Farmaceuticos and ENCE Energa

The main advantage of trading using opposite Laboratorios Farmaceuticos and ENCE Energa positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Laboratorios Farmaceuticos position performs unexpectedly, ENCE Energa can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ENCE Energa will offset losses from the drop in ENCE Energa's long position.

The idea behind Laboratorios Farmaceuticos ROVI and ENCE Energa y pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Anywhere module to track or share privately all of your investments from the convenience of any device.